Get started
Author

Alessandra Pompa

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma
2021 · Alessandra Larocca, Francesca Bonello, et al. · Blood · 83
PDF
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents
2015 · A. Romano, N. L. Parrinello, et al. · Annals of Hematology · 60
The possible role of burden of therapy on the risk of myeloma extramedullary spread
2016 · Silvia Mangiacavalli, A. Pompa, et al. · Annals of Hematology · 46
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias
2018 · Bernhard Gerber, Martina Manzoni, et al. · Haematologica · 41
PDF
Psychological care of caregivers, nurses and physicians: a study of a new approach
2014 · Maurizio S. Abeni, Margherita Magni, et al. · Cancer Medicine · 32
PDF
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials
2020 · Massimo Gentile, Giorgina Specchia, et al. · Haematologica · 30
PDF
Monoclonal gammopathy of undetermined significance: a new proposal of workup
2013 · Silvia Mangiacavalli, Federica Cocito, et al. · European Journal Of Haematology · 30
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial
2022 · Meletios A. Dimopoulos, Fredrik Schjesvold, et al. · Blood Cancer Journal · 20
PDF
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials
2023 · Massimo Gentile, Ernesto Vigna, et al. · Haematologica · 19
PDF
Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma
2020 · Martina Manzoni, Alessandra Pompa, et al. · HemaSphere · 19
Global methylation patterns in primary plasma cell leukemia
2018 · Katia Todoerti, Giovanni Calice, et al. · Leukemia Research · 19
Basal and After‐stimuli Test for Prolactinemia in Systemic Lupus Erythematosus
1999 · A. ZOLI, E. M. FERLISI, et al. · Annals of the New York Academy of Sciences · 19
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials
2022 · Antonella Bruzzese, Daniele Derudas, et al. · Hematological Oncology · 17
Primary plasma cell leukemia 2.0: advances in biology and clinical management
2016 · Antonino Neri, Katia Todoerti, et al. · Expert Review of Hematology · 16
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma
2018 · Alessandro Loglio, Mauro Viganò, et al. · Digestive and Liver Disease · 15
Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis
2013 · Alessandro Corso, Silvia Mangiacavalli, et al. · PLoS ONE · 15
PDF
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort
2022 · Matteo Claudio Da Vià, Marta Lionetti, et al. · Blood Advances · 11
PDF
Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial
2022 · Evangelos Terpos, Meletios A. Dimopoulos, et al. · American Journal of Hematology · 11
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
2020 · Martina Manzoni, Valentina Marchica, et al. · Cancers · 11
PDF
Correlation between burden of 17 P 13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma
2013 · Silvia Mangiacavalli, Lara Pochintesta, et al. · British Journal of Haematology · 11
PDF
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020 · Bruno Fattizzo, Juri Alessandro Giannotta, et al. · Blood Advances · 8
PDF
Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice
2019 · Federica Cocito, Silvia Mangiacavalli, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis
2022 · Silvia Mangiacavalli, Claudio Salvatore Cartia, et al. · Haematologica · 6
Four Cases of Lenalidomide-Associated Immune Thrombocytopenia
2016 · Alessandra Pompa, Francesca Guidotti, et al. · Blood · 6
Survey of current practice for monitoring and management of platelet refractoriness in Italy
2012 · Anna Quaglietta, Antonio Nicolucci, et al. · Transfusion and Apheresis Science · 6
Works count: 54
Citation count: 594
H-index: 15
I10-index: 20
Year
Topic
Type